Clinical Trials Browser

Phase 2 × dapagliflozin × 90 days × Clear all

NCT06427226 2026-04-17

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

Phase 2 Recruiting

Breast Neoplasms

NCT07018622 2026-03-11

DAPA-ARMOR

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors